期刊文献+

支气管哮喘治疗的准则和药物治疗现状及未来战略 被引量:2

Guideline for the Management of Bronchial Asthma,Current Drug Therapies and the Future Strategy
下载PDF
导出
摘要 简要地介绍了支气管哮喘治疗的准则和药物治疗现状及问题,强调了恰当应用肾上腺皮质激素的重要性。气道炎症是支气管哮喘持久性的原因。因而,应强调长期抗炎治疗,特别是对长期患哮喘的病人。 An outline of the current clinical guideline and drug therapies in the management of bronchial asthma with stressing on the proper use of oral and inhaled corticosteroids, and control released - fyllins is presented. Airway inflammation is a persistent feature of bronchial asthma. Thus, long - term and - inflammatory therapy is recommended, particularly for those with persistent asthma. The article also discussed problems in our practice, and the future strategy for the prevention and treatment of bronchial asthma in China.
作者 何权瀛
出处 《中国医药导刊》 1999年第1期35-38,共4页 Chinese Journal of Medicinal Guide
  • 相关文献

同被引文献3

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部